Multi-drug-resistant tuberculosis cost-effectiveness of therapy: Difference between revisions

	Multi-drug-resistant tuberculosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multi-drug-resistant tuberculosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Multi-drug-resistant tuberculosis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multi-drug-resistant tuberculosis cost-effectiveness of therapy
CDC on Multi-drug-resistant tuberculosis cost-effectiveness of therapy
Multi-drug-resistant tuberculosis cost-effectiveness of therapy in the news
Blogs on Multi-drug-resistant tuberculosis cost-effectiveness of therapy
Directions to Hospitals Treating Multi-drug-resistant tuberculosis
Risk calculators and risk factors for Multi-drug-resistant tuberculosis cost-effectiveness of therapy

Revision as of 20:24, 26 September 2014

The average cost of treating a person with TB disease increases with greater resistance.
Direct costs (in 2010 U.S. dollars) average from $17,000 to treat drug-susceptible TB to $430,000 to treat the most drug-resistant form of the disease (XDR TB). ^[1]

When including productivity losses (e.g., lost income) experienced by patients while undergoing treatment, costs are even higher.^[1]

@@ Line 4: / Line 4: @@
 ==Cost-effectiveness of therapy==
+*The average cost of treating a person with TB disease increases with greater resistance.
+*Direct costs (in 2010 U.S. dollars) average from $17,000 to treat drug-susceptible TB to $430,000 to treat the most drug-resistant form of the disease (XDR TB). <ref name="CDC"> {{cite web| url=http://www.cdc.gov/tb/topic/drtb/default.htm| title= CDC Drug-Resistant TB}}</ref>
+*When including productivity losses (e.g., lost income) experienced by patients while undergoing treatment, costs are even higher.<ref name="CDC"> {{cite web| url=http://www.cdc.gov/tb/topic/drtb/default.htm| title= CDC Drug-Resistant TB}}</ref>
 {|
 |[[File:The Costly Burden of MDR-TB.jpg|thumb|550px|left|Image obtained from CDC([http://www.cdc.gov/nchhstp/newsroom/2014/TB-Infographic2014.html?s_cid=nchhstp-nr-wtbd-004])]]